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Neurofeedback training builds upon the simple concept of instrumental conditioning, i.e. behaviour that is rewarded is more likely
to reoccur, an effect Thorndike referred to as the ‘law of effect’. In the case of neurofeedback, information about speciﬁc
electroencephalographic activity is fed back to the participant who is rewarded whenever the desired electroencephalography
pattern is generated. If some kind of hyperarousal needs to be addressed, the neurofeedback community considers sensorimotor
rhythm neurofeedback as the gold standard. Earlier treatment approaches using sensorimotor-rhythm neurofeedback indicated that
training to increase 12–15Hz sensorimotor rhythm over the sensorimotor cortex during wakefulness could reduce attention-deﬁcit/
hyperactivity disorder and epilepsy symptoms and even improve sleep quality by enhancing sleep spindle activity (lying in the same
frequency range). In the present study we sought to critically test whether earlier ﬁndings on the positive effect of sensorimotor
rhythm neurofeedback on sleep quality and memory could also be replicated in a double-blind placebo-controlled study on 25
patients with insomnia. Patients spent nine polysomnography nights and 12 sessions of neurofeedback and 12 sessions of placebo-
feedback training (sham) in our laboratory. Crucially, we found both neurofeedback and placebo feedback to be equally effective
as reﬂected in subjective measures of sleep complaints suggesting that the observed improvements were due to unspeciﬁc factors
such as experiencing trust and receiving care and empathy from experimenters. In addition, these improvements were not reﬂected
in objective electroencephalographic-derived measures of sleep quality. Furthermore, objective electroencephalographic measures
that potentially reﬂected mechanisms underlying the efﬁcacy of neurofeedback such as spectral electroencephalographic measures
and sleep spindle parameters remained unchanged following 12 training sessions. A stratiﬁcation into ‘true’ insomnia patients and
‘insomnia misperceivers’ (subjective, but no objective sleep problems) did not alter the results. Based on this comprehensive and
well-controlled study, we conclude that for the treatment of primary insomnia, neurofeedback does not have a speciﬁc efﬁcacy
beyond unspeciﬁc placebo effects. Importantly, we do not ﬁnd an advantage of neurofeedback over placebo feedback, therefore it
cannot be recommended as an alternative to cognitive behavioural therapy for insomnia, the current (non-pharmacological)
standard-of-care treatment. In addition, our study may foster a critical discussion that generally questions the effectiveness of
neurofeedback, and emphasizes the importance of demonstrating neurofeedback efﬁcacy in other study samples and disorders using
truly placebo and double-blind controlled trials.
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Introduction
Neurofeedback builds upon the simple principle of instru-
mental conditioning, that is, that behaviour which is re-
warded is more likely to reoccur in the future, an effect
also referred to as the ‘law of effect’ (Thorndike, 1905).
Speciﬁcally, in the case of neurofeedback information
about neural processes that are beyond wilful control—
such as the generation of speciﬁc EEG activity patterns—
is fed back to the participant and rewarded in the form of
auditory or visual cues or tokens. Various neurofeedback
training (NFT) protocols have been proposed and studied
for the treatment of a wide range of disorders (for review
see Hammond, 2011). Many of these protocols focus on
sensorimotor rhythm (SMR) training, where 12–15Hz at
EEG sites above the sensorimotor cortex (i.e. electrode pos-
itions C3 or C4) is rewarded. The rationale is that
enhanced SMR power will go hand-in-hand with increased
relaxation or inhibition of (motor) activity (Sterman, 2000),
which should counteract the hyperarousal linked to some
prevalent disorders. Speciﬁcally, SMR-NFT has been read-
ily used for the treatment of epilepsy (Tan et al., 2009) and
ADHD (Arns et al., 2014) with usually clear beneﬁcial out-
comes. Besides this, Sterman et al. (1970) was able to show
in his pioneering work that when cats are trained to in-
crease EEG power in the (12–14Hz) SMR frequency band
during wakefulness, they also presented with more sleep
spindles and enhanced sleep quality (i.e. less fragmentation)
during subsequent sleep. This is intriguing not only because
it suggests that NFT training effects may translate to other
vigilance states (i.e. from wakefulness to sleep), but it im-
portantly also suggests a possible treatment for insomnia, a
burden that is estimated to affect between 10 and 35% of
the general population worldwide (Morin et al., 2006b).
One mechanism that has been proposed to explain
Sterman’s ﬁndings is that the SMR frequency band signiﬁ-
cantly overlaps with the 12–15Hz frequency range in
which sleep spindles occur during non-REM sleep.
Eventually, an increase in spindle activity may account
for the improvements in sleep quality (i.e. shorter sleep
onset latency and less sleep fragmentation) observed.
However, despite the burden insomnia depicts for our so-
ciety, only few studies followed-up on Sterman’s ﬁndings
(Hauri, 1981; Hauri et al., 1982; Cortoos et al., 2010) with
all of them attesting neurofeedback beneﬁcial effects on
sleep.
Despite these promising ﬁndings, solid research on neu-
rofeedback almost came to a standstill (for critical discus-
sion see Thibault and Raz, 2016), and much of the
knowledge we have about NFT today is derived from
classic studies conducted in the 1980s. In the present
study we aimed to resume and extend beyond those studies,
and speciﬁcally build on our earlier ﬁndings (for review see
Hoedlmoser et al., 2011), which indicated positive effects
of SMR-NFT in young healthy individuals (Hoedlmoser
et al., 2008) and young patients with subclinical insomnia
(Schabus et al., 2014). In particular, results indicated a
beneﬁcial effect of only 10 sessions of 12–15Hz SMR-
NFT training on sleep quality and memory performance
(Hoedlmoser et al., 2008) or even overnight memory con-
solidation (Schabus et al., 2014). The latter ﬁnding is espe-
cially relevant from a clinical perspective as insomniacs
frequently complain about problems related to attention
and memory. However, the external validity of these ﬁnd-
ings and eventually the translation into clinical practice
may be hampered by limitations such as a single blind
study design and the lack of follow-up assessments.
Besides this, earlier results obtained in a subclinical insom-
nia sample indicated a placebo effect with participants feel-
ing better from visit to visit independent of whether they
received NFT or placebo feedback training (PFT) (cf. Fig. 6
in Schabus et al., 2014), a ﬁnding that is in line with con-
clusions drawn by Thibault et al. (2015) in a recent review.
Importantly, in our PFT condition participants also
received real EEG feedback; however, not about SMR,
but varying frequency bands, i.e. each training session
they received feedback on a different frequency band.
To circumvent the above mentioned limitations and to
obtain a reliable and valid evaluation of the usefulness of
SMR-NFT for the treatment of primary insomnia, we here
adopted a counterbalanced double-blind cross-over design
in a sample of patients with primary insomnia. As we here
ﬁnd that NFT positively affects subjective measures, yet is
ineffective in changing objective parameters such as spectral
EEG measures, sleep architecture or memory performance,
we post hoc added an additional healthy NFT control
group (undergoing identical SMR-NFT training) to repli-
cate the effectiveness of our NFT protocol that had previ-
ously been established (Hoedlmoser et al., 2008). This
young healthy control group underwent the same proced-
ure as did the clinical sample, but exclusively received NFT.
The protocol for all patients comprised multiple meetings
for psychometric testing, nine nights in the laboratory with
polysomnography recording (i.e. one adaptation/screening
as well as two pre- and two post-treatment nights ﬂanking
the PFT and NFT blocks), 12 PFT and 12 NFT sessions.
More speciﬁcally, the NFT training protocol was akin to
the one used in previous studies from our group
(Hoedlmoser et al., 2008; Schabus et al., 2014) with feed-
back consisting of information about SMR EEG power
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above a central brain area (electrode C3) and no simultan-
eous block/inhibit ﬁlters to ensure that patients actually
would be able to learn increasing their SMR rhythm
within 12 sessions. We chose to only include 12 sessions
of NFT as non-pharmacological treatment alternatives such
as cognitive behavioural therapy for insomnia (CBT-I,
Morin et al., 2006a; Riemann et al., 2015) are known to
be successful with as few as four to eight sessions.
In summary, the aim was to replicate previous results and
verify the clinical efﬁcacy of SMR-NFT in a sample of pri-
mary insomnia patients adopting a double-blind study
design.
Materials and methods
Ethics
The present study was conducted in accordance with the
Declaration of Helsinki, approved by the local ethics commit-
tee (‘Ethikkommission Paris Lodron-Universita¨t Salzburg’),
and registered at the German Clinical Trials Register
(DRKS00003265). Participants gave written informed consent.
Some of the data presented here (i.e. the data concerning sleep-
dependent memory consolidation) have partly been published
in Griessenberger et al. (2013).
Participants
With an a priori power analysis using G*Power we determined
a sample size of at least 21 subjects to be sufﬁcient to reach a
power of 0.80 for our predeﬁned primary endpoints, that is,
increase in sleep spindle activity and decrease in sleep onset
latency. We had found large effect sizes (Cohen’s d, 0.86 to
1.19) in a previous NFT study of our group (Hoedlmoser
et al., 2008) for these primary endpoints. To be able to also
reliably detect these changes in a clinical sample of patients
with insomnia, we aimed for a sample size of 30 subjects.
We thus recruited 30 patients with primary insomnia [mean
age = 38.59, standard deviation (SD) = 11.18, 19 females],
who underwent NFT and PFT. An additional control group
underwent NFT only (neurofeedback control, mean
age = 26.67, SD = 4.46, six females) but, importantly, did not
sleep in the lab and did not undergo PFT. This group was
included to obtain normal NFT learning curves in the absence
of any insomnia complaints and veriﬁed the efﬁcacy of our
NFT protocol (Hoedlmoser et al., 2008).
Besides these two groups, we also included 31 age- and sex-
matched healthy sleep controls (mean age = 35.52, SD = 10.63,
19 females) in the study. Importantly, this group did not
undergo NFT or PFT, but only completed ‘Visit 1’ (Fig. 1)
to obtain age- and sex-matched standard values for sleep
and memory parameters. Insomnia patients were diagnosed
according to the research criteria of Edinger et al. (2004)
and had been free of medication for at least 2 weeks prior
to study onset. Following an eligibility assessment [medical
history, Pittsburgh Sleep Quality Index Questionnaire (PSQI),
depression and anxiety questionnaires via email and phone]
patients attended the lab where they were screened overnight
more thoroughly for psychiatric disorders according to DSM-
IV (American Psychiatric Association, 1995) using the
Structured Clinical Interview for DSM disorders. They also
completed additional questionnaires such as intelligence and
personality questionnaires. Sleep controls did not have any
history of past or current psychiatric disorders, which was
veriﬁed through clinical interviews and the PSQI questionnaire
(PSQI score4 5; Buysse et al., 1989). Additionally, sleep con-
trols could only take part in the study if their sleep efﬁciency
during the screening night was51 SD below the average sleep
efﬁciency in age- and sex-matched healthy sleepers (according
to a European database: mean = 88.97; SD = 6.7; Anderer
et al., 2005). Patients received a remuneration of e500 after
study completion (e150 for block 1, and e350 for block 2)
whereas the control group received e100. Recruitment was
through announcements in local newspapers, radio, ﬂyers at
general practitioners’, and via our laboratory homepage.
For statistical analyses, we excluded ﬁve healthy controls
(sleep controls) with abnormal sleep values (mean sleep efﬁ-
ciency580%, mean wake after sleep onset4 50min in two
polysomnography nights). We also excluded ﬁve with insom-
nia as they did not complete both study parts (i.e. NFT and
PFT) or missed multiple polysomnography nights. Importantly,
we noticed that some patients with insomnia did not present
with objective sleep problems (i.e. decreased sleep efﬁciency or
increased waking after sleep onset) although all their subjective
measures qualiﬁed them as primary insomnia patients. This
subgroup of nine patients with insomnia exceeded a sleep ef-
ﬁciency of 90% and neither showed a sleep onset latency or
wake after sleep onset exceeding 30min on more than half of
the laboratory nights (i.e. four of eight nights following the
screening night), therefore we considered these patients not as
patients with insomnia, but ‘sleep state misperception’ patients
(misperception insomniacs). This subgroup was handled as an
additional group in the statistical analyses. In conclusion, we
included up to four different groups in our statistical analyses,
i.e. patients with insomnia (n = 16), misperception insomniacs
(n = 9), sleep control subjects (n = 26), and neurofeedback con-
trol subjects (n = 12).
Experimental design
After the eligibility assessment, patients with insomnia, misper-
ception insomniacs and sleep control subjects slept in the la-
boratory for a screening night to exclude sleep disorders other
than insomnia. Thereafter, two experimental nights followed
(referred to as ‘Visit 1’ in the following). Each of these two
nights was accompanied by either a procedural (ﬁnger-tapping
task) or a declarative (word-pair association) memory task. As
this study focuses on neurofeedback effects on EEG, sleep and
quality of life in insomnia patients, we refrain from discussing
the results from these memory tasks in further detail
(Supplementary material). Before and after each night, subjects
completed questionnaires regarding subjective sleepiness
(Stanford Sleepiness Scale; Hoddes et al., 1972) and mood
[Multidimensional Mood Questionnaire (MDBF); Steyer
et al., 1997] and performed the psychomotor vigilance task
(Dinges and Powell, 1985).
Patients with insomnia underwent this procedure four times
(Visits 1–4) whereas sleep control subjects only completed the
ﬁrst visit (see above). In between the ﬁrst and second, as well
as the third and fourth of these visits, patients with insomnia
completed 12 sessions of NFT and 12 sessions of PFT, i.e.
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a placebo or sham condition (with real EEG feedback, yet on
varying frequency bands) (Fig. 1). The order of trainings (NFT
or PFT) was counterbalanced across subjects and the 12 ses-
sions were completed within  2–4 weeks. Besides this, partici-
pants’ sleep-wake cycle was assessed using sleep diaries and
actigraphy (Cambridge Neurotechnology Actiwatch) over the
course of the whole protocol.
Neurofeedback and placebo-feedback methodology
In the 12 NFT or PFT training sessions, subjects learned to
enhance EEG amplitudes within a speciﬁc frequency range
while visual feedback was given online by the Eldith THERA
PRAX (neuroConn) system. Each neurofeedback or instrumen-
tal conditioning session (NFT and PFT) consisted of eight 5-
min training blocks (with 13–25 trials within each block).
Beyond this, the NFT protocol also included two ‘transfer
conditions’ in which no immediate online feedback on the per-
formance was given, but simply the reward or next trial sign at
the end of the training block. The transfer blocks were
included to better enable patients to apply the NFT technique
at home, i.e. in the absence of NFT machinery and thus allow
for a better transfer to the real world. For later NFT/PFT
analyses only the six 5-min blocks with feedback were con-
sidered. Before the start and at the end of each training ses-
sion, resting EEG activity was recorded during 2min with eyes
closed and 2min with eyes open. Only the resting EEG record-
ings obtained during the eyes open period are of interest for
the analyses presented here, therefore we refer to these record-
ings when mentioning resting state EEG hereafter.
The NFT/PFT training protocol used followed earlier studies
from our group (Hoedlmoser et al., 2008; Schabus et al.,
2014). Speciﬁcally, one trial consisted of a 3 s baseline meas-
urement followed by a continuous feedback interval lasting
until the EEG signal exceeded (for at least 250 ms) the prede-
ﬁned reward threshold established during the baseline. During
the feedback interval, participants had to mentally ‘move’ a
compass needle as far to the left as possible reaching the
previously ﬁxed threshold represented by a green dot
(Supplementary Fig. 1). Subjects were instructed to test appro-
priate strategies and ﬁnd their personally most successful ap-
proach to mastering the task. They were told that, for
example, a combination of relaxation techniques and positive
thought might help them exceed the threshold. After the ap-
pearance of the reward signal the next trial started with a new
3 s baseline measurement. Every 5min there was a pause of
1min before the training continued with the next training
block. To prevent rewarding artefacts or ‘non-neural’ strate-
gies, trials with movements, eye or muscle artefacts as well as
trials with amplitudes exceeding 200mV were abandoned
and a new trial was started automatically. Importantly,
during the NFT condition, participants had to enhance EEG
amplitudes in the SMR range between 12 and 15Hz, whereas
during the PFT sessions participants had to enhance random
frequency ranges between 7 and 20 Hz (but not the 12–15Hz
SMR range); importantly within a PFT session only one fre-
quency was trained and rewarded. The reason for choosing
this kind of placebo or sham protocol was to involve patients
to a similar degree as in NFT, yet with no speciﬁc frequency
being rewarded systematically. Rewarding another frequency
systematically could have resulted in undesired effects on
EEG and behaviour that would render the PFT control condi-
tion suboptimal.
To keep motivation balanced across NFT and PFT condi-
tions and training blocks we adjusted the threshold in such a
way that within each of the eight 5min training blocks it was
always similar amounts of reward that were given. Speciﬁcally,
if less than 13 rewards were received in a 5min block we
lowered the threshold to be exceeded. Likewise, if more than
25 rewards were achieved, we increased the threshold that had
to be exceeded. All patients (misperception insomniacs and
patients with insomnia) had to complete both NFT and PFT
sessions and were blind to the condition they were in at any
point of the protocol. Contrary to earlier studies (Hoedlmoser
et al., 2008; Schabus et al., 2014), the investigators were also
Figure 1 Study design. After participants had undergone an eligibility assessment (via email and phone) they came to the laboratory for a
screening night to exclude sleep disorders besides insomnia. Then subjects completed four visits each, each one comprising two experimental
nights with polysomnography (either preceded by a declarative or procedural learning task). In between Visits 1 and 2, and 3 and 4 all patients
(patients with insomnia, misperception insomniacs) completed 12 sessions of NFTand PFT. Between Visits 2 and 3, a 3-month washout period was
introduced and a final follow-up after 3 months was conducted. The order of NFTand PFTwas counterbalanced (half of the patients receiving NFT
first, and half of the patients receiving PFT first) and the protocol was kept double-blind until study completion.
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blind to the condition using a NFT/PFT code list simply stating
‘training frequency A–F’ for each of the 24 training sessions
(i.e. ‘third party concealment’). There was no monetary reward
linked to training success; overall all participants seemed
(given their psychological strain related to their chronic insom-
nia complaints) highly motivated throughout the training
protocols.
EEG recordings
EEG recordings were done using Synamps EEG ampliﬁers
(NeuroScan Inc.) with a sampling rate set to 500Hz. The
EEG setup comprised 22 scalp electrodes (Fp1, Fpz, Fp2, F3,
Fz, F4, F8, T3, C3, Cz, C4, T4, T5, P3, Pz, P4, T6, O1, Oz,
O2 plus the mastoids A1 and A2 for later ofﬂine re-referen-
cing), one bipolar horizontal (HEOG) and one bipolar vertical
electrooculogram (VEOG), one bipolar electrocardiogram
(ECG) channel, one bipolar electromyogram (EMG) channel
and one respiratory channel (chest wall movements). During
the screening polysomnography we used a reduced setup with
eight EEG, one bipolar ECG, two bipolar EOG, four respira-
tory measures (nasal airﬂow, chest and abdominal wall move-
ments, oxygen saturation) and four unipolar EMG (submental
and left/right tibialis nerve) electrodes. All scalp electrodes
were placed according to the international 10-20 system
(Jasper, 1958). Sleep was scored automatically by the
SOMNOLYZER 24*7 (The Siesta Group) and veriﬁed manu-
ally by a sleep scoring expert following sleep scoring criteria of
the American Academy of Sleep Medicine (AASM; Iber et al.,
2007).
Sleep spindle detection
Sleep spindles were detected automatically at frontal, central
and parietal electrodes (F3, C3, P3) re-referenced to the
contralateral mastoid electrodes. The spindle detection algo-
rithm was based on the following criteria: (i) 11 to 16Hz
band-pass ﬁltering; (ii) amplitude 425 mV; (iii) duration
40.5 s; and (iv) no muscle (30–40Hz) and/or alpha (8–
12Hz) artefacts (for details see Schimicek et al., 1994). The
algorithm computes spindle activity, which reﬂects duration
and amplitude of spindles, and therefore quantiﬁes the inten-
sity of the spindle process (during non-REM sleep stage N2).
Furthermore, we distinguished between slow (11–13Hz) and
fast (13–15Hz) spindles and provide a measure of spindle
density [spindle number per N2 sleep duration (min)].
EEG spectral analyses
EEG analyses were performed with BrainVision Analyzer 2.0
(Brain Products). In a ﬁrst step, data were bandpass-ﬁltered
between 0.5 and 70Hz and a 50Hz notch ﬁlter was applied.
Ocular artefacts were corrected for (Gratton et al., 1983) and
remaining artefacts were excluded manually. Afterwards, data
were segmented into epochs of 2 s and a fast Fourier trans-
formation was applied to obtain amplitude values in the fre-
quency domain and ﬁnally we averaged values in the desired
frequency range. We decided to focus on the trained 12–15Hz
frequency band (i.e. SMR) as well as the neighbouring 16–
25Hz beta band, which has been associated with hyperarousal
upon falling asleep in insomnia subjects (Perlis et al., 2001). In
addition, we checked for changes in the theta (5–7Hz) range
as an increase in theta amplitude is supposed to indicate
drowsiness. For analyses we selected electrodes C3 (used for
feedback during NFT/PFT) and the contralateral electrode C4.
Statistical analyses
Data were statistically tested (IBM

SPSS

Statistics, Version
23; SPSS Inc., Chicago, Illinois) using repeated measures ana-
lyses of variance (ANOVAs) after having controlled for normal
distribution of the data using the Kolmogorov-Smirnov test.
Generally, we statistically evaluated (i) EEG effects during
NFT/PFT; (ii) short-term EEG effects following NFT/PFT;
and (iii) long-term effects of NFT/PFT on objective and sub-
jective sleep parameters.
To investigate effects during training, we computed an
ANOVA and tested for changes in EEG power in the SMR
frequency range at electrode C3 (% change to baseline) during
NFT and PFT training as compared to the 3 s baseline preced-
ing each trial. This ANOVA included the factors Time (10
sessions, as due to technical problems data from Sessions 2
and 12 had to be discarded), Feedback (NFT versus PFT)
and Group (patient with insomnia versus misperception insom-
niac). A supplementary analysis also investigated changes in
the theta and beta frequency range, and compared effects at
the trained electrode site C3 as well as the contralateral site C4
(Supplementary material).
Short-term EEG effects following NFT/PFT in the SMR (12–
15Hz) frequency range, i.e. training effects on the resting state
EEG acquired immediately after NFT/PFT were tested in a
repeated measures ANOVA with the within-subject factors
Feedback (NFT versus PFT), Electrode (C3 versus C4), Time
(12 training blocks) and Pre/post-training (before and after
each training session). For this ANOVA we pooled both pa-
tient groups, i.e. patients with insomnia and misperception
insomniacs. An identical ANOVA was computed for 16–
25Hz beta amplitude as this frequency range has previously
been related to hyperarousal in insomnia. Resting state ampli-
tudes are normalized to the individual total amplitude (1–
30Hz) to account for unspeciﬁc differences (e.g. skull thick-
ness) between participants.
For evaluating long-term effects on objective sleep param-
eters and sleep spindles we always computed the mean of
the two experimental nights preceding or following NFT/PFT.
Speciﬁcally, long-term effects of NFT/PFT on objective sleep
parameters were evaluated using the nights ﬂanking NFT and
PFT, and taking the patient with insomnia and misperception
insomniac group separately into account. The resulting
ANOVA consisted of the factors Stage (Wake, N1, N2, N3,
R in min), Feedback (NFT versus PFT), Pre/post (before and
after each training block or Visit 1 to 2, and Visit 3 to 4) and
Group (patients with insomnia, misperception insomniac).
Long-term effects of NFT/PFT were also computed on sleep
spindles, which were hypothesized to change as a result of
SMR-NFT training. An ANOVA was conducted for the NFT
as well as PFT training effects with the factors Pre/post, spindle
type (slow versus fast spindles), the between-subject factor
Group (patients with insomnia, misperception insomniacs)
and the dependent measures (i) sleep spindle activity; and (ii)
sleep spindle density at (trained) electrode C3.
Last but not least, we computed long-term effects on sub-
jective measures of sleep and life quality. An ANOVA with the
factors Pre/post, Feedback and the between-subject factor
Group (patients with insomnia versus misperception
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insomniacs) was run for the dependent measures subjective
sleep quality (as assessed by the PSQI) and quality of life (as
assessed by the World Health Organization Quality of Life
Assessment; Skevington et al., 2004). For 15 patients with in-
somnia and eight misperception insomniacs we obtained all
four PSQI measures (i.e. one from each of the four visits)
plus one additional follow-up after 3 months. To assess the
stability of the subjective sleep quality changes we ﬁnally per-
formed paired-sample t-tests from the last training block
(which could be NFT or PFT) to the follow-up. Post hoc t-
tests following-up signiﬁcant main effects or interactions of
interest were corrected for multiple comparisons using the
false discovery rate (FDR) method by Benjamini and
Hochberg. The alpha-level used to determine signiﬁcance was
set to 0.05. For the evaluation of effect sizes we report partial
eta-squared (p
2) as computed by SPSS for repeated measures
ANOVAs.
Results
EEG effects during NFT/PFT
Conﬁrming our expectations, we found signiﬁcant differ-
ences between the two training conditions (i.e. NFT and
PFT) and our patient groups (i.e. patients with insomnia
and misperception insomniacs) when looking at objective
EEG changes following NFT and PFT (Fig. 2).
An ANOVA concentrating on the SMR frequency range
revealed main effects for the factors Time [F(9,153) = 4.981;
P5 0.001; p
2 = 0.227] and Feedback [F(1,17) = 20.536;
P5 0.001; p
2 = 0.547]. Latter main effect highlights that
SMR-power was found to be higher for NFT
(mean = 19.638; SD = 2.26) than PFT (mean = 8.753;
SD = 2.22) (across all 12 training sessions). This effect was
independent from whether patients were classiﬁed as patients
with insomnia or misperception insomniacs.
Speciﬁcally, misperception insomniacs during NFT
(mean = 24.29; SD = 7.56) outperformed patients with in-
somnia (P5 0.001) and misperception insomniacs during
PFT (P = 0.013) as a group, meaning that misperception
insomniac patients in the NFT condition were showing
higher SMR changes to the baseline than did patients
with insomnia and misperception insomniacs during PFT.
Patients with insomnia during NFT (mean = 18.04;
SD = 9.68) were only showing higher SMR power than
when training under PFT conditions (mean = 5.57;
SD = 8.68; P50.001) but did not outperform any other
group.
All reported effects are stronger on the trained electrode
site C3, yet they do transfer to the contralateral site, that is,
C4 as illustrated in Supplementary Figs 2 and 3. In conclu-
sion, we found evidence that both patients with insomnia
and misperception insomniacs are able to upregulate the
amplitude of the SMR frequency range after 12 training
sessions. A supplementary analysis (Supplementary mater-
ial) further conﬁrms that the amount of SMR enhancement
(to the baseline) achieved in our patients is not statistically
different from a young healthy control group (neurofeed-
back control) conducting identical SMR-NFT.
Short-term effects of NFT/PFTon
EEG
To evaluate short-term effects of NFT/PFT training, we
checked for differences in the EEG measurements between
Figure 2 Effects of NFT/PFT training on SMR band power during training. Note that as a group all patients [patients with insomnia
(INs), misperception insomniacs (MPs)] were able to significantly increase power in the SMR frequency band during NFT (as compared to PFT). A
group of young healthy neurofeedback controls (NC) is plotted for comparison. Note that the x-axis informs about the rewarded frequency bands
for PFT and NFT. Training sessions 2 and 12 are not displayed due to technical problems.
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the resting state recordings that preceded and immedi-
ately followed the trainings but found no changes
across the 12 NFT/PFT training sessions. Please note
that we here will exclusively focus on the trained SMR
frequency range (see Supplementary material for add-
itional information in the beta range). An ANOVA of
the SMR frequency band showed that the type of feed-
back used during training (i.e. NFT versus PFT) did not
have an effect in this frequency band that outlasted the
training itself. Speciﬁcally, neither the main effects of
Time [F(11,242) = 0.624, P = 0.792; p
2 = 0.028] nor
Pre/post-training were signiﬁcant [F(1,22) = 0.677,
P = 0.419; p
2 = 0.030]. However a nearly signiﬁcant
main effect for the factor Electrode [F(1,22) = 4.233,
P = 0.052; p
2 = 0.161] indicated that directly following
training SMR was higher on the trained electrode C3
than on C4. No further interactions reached signiﬁcance.
Long-term effects of NFT/PFTon
objective and subjective sleep
parameters
Long-term effects on objective sleep parameters
For all objective measures of sleep architecture we did
not ﬁnd any signiﬁcant changes across PFT or NFT train-
ing blocks. Only a Stage  Group interaction reached
signiﬁcance [F(4,92) = 9.736, P5 0.001; p
2 = 0.30] and
indicated that patients with insomnia presented with
more wake time, yet less N2, N3 and REM than misper-
ception insomniacs. Subjective total sleep time and sleep
onset latency (derived from the PSQI) were also evaluated
before and after the NFT/PFT training blocks but like-
wise revealed no signiﬁcant changes. See Table 1 for a
listing of all sleep parameters before and after NFT/PFT
and separately for patients with insomnia and mispercep-
tion insomniacs.
Long-term effects on sleep spindles
Analyses of long-term effects of NFT/PFT training on
sleep spindle measures did not indicate that these meas-
ures increased by any type of training (Fig. 4).
Importantly, that suggests that besides the lack of
short-term effects, NFT does not seem to be efﬁcacious
regarding these EEG-derived measures in the long run
either. An ANOVA for the dependent measure spindle
activity in the NFT condition revealed no main effects
for the factors Pre/post-training [F(1,23) = 2.153,
P = 0.16; p
2 = 0.09], spindle type [F(1,23) = 0.005,
P = 0.94; p25 0.01], the between-subject factor Group
[F(1,23 = 0.077, P = 0.78; p2 = 0.03] or any of the inter-
actions. An ANOVA for the dependent measure spindle
density in the NFT condition revealed only a main effect
for the factor Type [F(1,23 = 38.322, P5 0.001;
p2 = 0.63] indicating a higher spindle density for the
fast spindle type on electrode C3. This was generally ex-
pected as the number of fast spindles is usually higher atT
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centro-parietal sites as compared to (more frontal) slow
spindles (Anderer et al., 2001). Neither the factor Pre/
post-training [F(1,23) = 0.244, P = 0.63; p2 = 0.01], nor
the between-subject factor Group [F(1,23) = 0.173,
P = 0.68; p2 = 0.01] or any of the interactions were
signiﬁcant.
For the PFT condition an ANOVA for the dependent
measure spindle activity revealed no main effect for the
factor Type [F(1,22) = 0.005, P = 0.94; p25 0.001], or
the between-subject factor Group [F(1,22) = 0.297,
P = 0.59; p
2 = 0.013] nor were any of the interactions sig-
niﬁcant. Yet, one main effect was marginally signiﬁcant,
with the factor Pre/post-training [F(1,22) = 3.298,
P = 0.083; p
2 = 0.130] indicating a trend towards
decreased spindle activity after PFT.
For the dependent measure spindle density only a main
effect for the factor Type [F(1,22) = 46.572, P5 0.001;
p
2 = 0.679] was signiﬁcant, again indicating an increased
prevalence of fast spindles on the central recording site C3
as compared to slow spindles. In summary, sleep spindle
activity, as well as sleep spindle density, were not affected
by NFT or PFT.
Long-term effects on subjective sleep quality and
quality of life
Contrasting objective EEG-derived measures, NFT training
did have a beneﬁcial effect on subjective measures of sleep
quality. To a lesser extent, that was also true for subjective
(physical) quality of life. Analyses revealed a main effect for
the factor Pre/post-training [F(1,21) = 7.621, P = 0.01;
p
2 = 0.266]. Speciﬁcally, subjective sleep complaints
decreased from pre- to post-training. Yet, no other effects
for the factors Feedback [F(1,21) = 0.169, P = 0.69;
p
2 = 0.008], or the between-subject factor Group
[F(1,21) = 1.598, P = 0.22; p
2 = 0.071] were signiﬁcant
(Fig. 5). Importantly, also the interaction Pre/post
training  Feedback [F(1,21) = 0.109, p = 0.75; p2 = 0.005]
was not signiﬁcant, nor was the three-way interaction Pre/
post training  Feedback  Group [F(1,21) = 0.010,
P = 0.92; p
2 = 0.0] signiﬁcant. Overall, the ANOVA thus
shows a signiﬁcant decrease of subjective sleep complaints,
which is independent from the type of feedback (i.e. NFT
versus PFT) and independent from whether they were pa-
tients with insomnia or misperception insomniacs.
Finally, we compared the evolution of the subjective sleep
complaints following the last training block to the follow-
up after 3 months. Paired-sample t-tests revealed a margin-
ally signiﬁcant further improvement (from mean = 5.50,
SD = 2.91 to mean = 4.58, SD = 3.15) for the patients
who had ended their training with PFT [t(11) = 2.200,
P = 0.050, d = 0.299]. This was however not true for pa-
tients who had terminated the study protocol with NFT
training [from mean = 7.73, SD = 3.74 to mean = 6.82,
SD = 4.22; t(10) = 1.311, P = 0.22, d = 0.224]. In general
effect sizes indicate a small positive effect for the change
in subjective sleep quality from pre- to post-training.
Despite positive effects of training on subjective measures
of sleep quality, quality of life remained unaffected.
Subjective quality of life as assessed by the The World
Health Organization Quality of Life Assessment did like-
wise not indicate a systematic increase of life quality over
the NFT or PFT sessions (Supplementary Fig. 5). Yet,
focusing on the World Health Organization Quality of
Life Assessment subdimensions we were able to conﬁrm
the unspeciﬁc increase of physical quality of life (incorpor-
ating facets such as fatigue, physical discomfort or work
capacity) from the ﬁrst experimental polysomnography
night to the 3-month follow-up [t(22) =  3.531,
P = 0.002] as reported previously (Schabus et al., 2014)
(Supplementary Fig. 6).
Last but not least, subjective awakening quality (i.e.
morning sleepiness as assessed by the Stanford Sleepiness
Scale, and mood after awakening as assessed by the MDBF
questionnaire) was unaffected by NFT/PFT training
(Supplementary material).
Discussion
To the best of our knowledge, we here present the ﬁrst
rigorously controlled study on the efﬁcacy of NFT for in-
somnia since the promising ﬁndings obtained in pioneering
studies by Sterman et al. (1970), Hauri (1981) and Hauri
et al. (1982). The present study (i) provides support for the
principle of NFT, i.e. that participants can learn to control
neural processes when they receive adequate feedback; and
(ii) ﬁnds positive evidence that such feedback can diminish
the subjective burden of a disease. Critically though, the
results call into question whether the positive ﬁndings re-
ported for NFT in the literature are indeed NFT-speciﬁc or
whether they are due to rather unspeciﬁc effects, such as
receiving attention, care and support from experimenters.
Unfortunately, well-controlled studies that may help dis-
entangle NFT-speciﬁc and unspeciﬁc therapeutic effects
underlying efﬁcacy are sparse in the ﬁeld, thus eventually
rendering a reliable evaluation of the efﬁcacy of this kind of
‘neurotherapy’ difﬁcult. Although some controlled studies
do exist for example for the treatment of attention deﬁcit
hyperactivity disorder (ADHD) symptoms (Arns et al.,
2009; Gevensleben et al., 2009), still the majority of them
lacks a real placebo group (e.g. groups of different training
duration or intensity) making it impossible to evaluate the
speciﬁc effects of NFT training. The importance of well-
controlled studies is further underlined by recent reports
that even the few studies that actually included placebo
conditions do not ﬁnd neurofeedback to be superior to
placebo or ‘sham’ feedback (Vollebregt et al., 2014;
Thibault et al., 2015; Thibault and Raz, 2016).
Moreover, sample sizes are often small and many studies
solely rely on subjective ratings rather than reporting ob-
jective changes in EEG parameters or other neural measures
that are expected to change through the feedback.
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Generally, we found that participants can obtain control
of otherwise unconscious neural processes with the help of
feedback thereby supporting the basic rationale behind this
family of therapeutic approaches. Speciﬁcally, our results
suggest that regulation of EEG activity, at least in narrow
frequency bands (here 12–15Hz or SMR oscillations) can
be learned quickly so that participants successfully perform
according to instructions and feedback. In addition, our
results suggest that the ability to learn may also depend
on general learning abilities of the individual with young
healthy subjects (i.e. the neurofeedback control group)
appearing to learn more quickly and exhibiting steeper
learning curves than patients with insomnia (Fig. 2).
Speciﬁcally, healthy neurofeedback control subjects already
seem to level off after a single NFT session (i.e. 8  5min
training) whereas patients need four (in misperception in-
somniacs) to six (in patients with insomnia) training ses-
sions to achieve a similar effect. Interestingly, this learning
effect was not limited to the NFT condition, but it was also
evident in the sham or PFT condition (with 15–20 Hz Beta
enhancements) (Supplementary Fig. 3) thus further backing
the notion of general learning deﬁcits limiting NFT success.
Beyond this, these ﬁndings also question other reports
advocating that neurofeedback training needs to comprise
at least 20–40 and sometimes even up to 50 training ses-
sions in order to be effective (Hammond, 2011). More
training sessions may indeed be necessary when working
with participants with more pronounced learning difﬁcul-
ties or if a successful transfer to the real-world without a
neurofeedback device is desired. Yet given the absence of
even short-term EEG effects immediately following the
NFT sessions it is unlikely that increasing the number of
training sessions will change the general outcome. One
might argue that patients simply did not learn to control
their SMR activity well enough to earn beneﬁts such as
improved sleep or memory consolidation. However, that
seems implausible, given the fact that misperception insom-
niac patients as compared to young healthy neurofeedback
control subjects even reach identical NFT learning levels
(over the 12 training sessions).
For NFT to be recommended for the treatment of pri-
mary insomnia, NFT has to (i) outperform a placebo con-
dition; (ii) bring about positive effects in the long run; and
(iii) ideally be as rapidly acting as the current (non-pharma-
cological) standard-of-care treatment. In our study, patients
who underwent the training protocol (i.e. NFT or PFT) did
report an improvement in subjective sleep quality and
(physical) quality of life when asked 3 months after
having completed the training protocol, i.e. during the
follow-up. Generally, this improvement on subjective in-
somnia complaints is in accordance with earlier results ob-
tained by other groups (Hauri, 1981; Cortoos et al., 2010)
as well as in our laboratory (Schabus et al., 2014). As the
current study is characterized by an increase in external
validity due to the design being highly controlled (i.e.
double-blinded and including a placebo or ‘sham’ condi-
tion) and validated in a bigger sample, it provides credible
support for the notion that NFT/PFT is able to improve
insomnia symptoms. Besides this, similar subjective im-
provements following EEG neurofeedback have been
found in studies involving samples of children with
ADHD (Lansbergen et al., 2011; Arnold et al., 2013; van
Dongen-Boomsma et al., 2013). Crucially however,
revealed improvements were independent of the type of
feedback training (i.e. NFT or PFT) patients underwent.
Essentially, this suggests that while subjective effects are
indeed stable in the long run, the observed improvements
were rather due to unspeciﬁc therapeutic than to NFT-spe-
ciﬁc factors. Thus, the current study implies, in line with
recently published ﬁndings (Arnold et al., 2013; Thibault
et al., 2015), that NFT is not systematically superior to
other placebo or ‘sham’ feedback conditions; at least not
at durations comparable to current standard-of-care treat-
ments (CBT-I).
Besides using subjective measures, we importantly also
aimed at evaluating objective measures of symptom reduc-
tion. To our surprise, however, the observed changes in
subjectively reported sleep quality were not accompanied
by any changes in objective EEG-derived measures of
sleep quality. Speciﬁcally, we expected positive changes in
sleep onset latency (Hoedlmoser et al., 2008) and/or the
number of awakenings and the amount of slow-wave
sleep (Schabus et al., 2014). The more severe nature of
the insomnia symptoms and the higher age in the current
study (i.e. a kind of ‘learning deﬁcit’ as discussed above)
may be one reason for the patients in this double-blind
protocol not objectively improving despite the earlier ﬁnd-
ings. On the other hand, (earlier) single-blind designs suffer
from the inherent risk that that laboratory staff and experi-
menters may inadvertently bring about the desired effects,
for example by subtly paying more attention to the pa-
tients’ complaints and needs in the NFT condition.
Indeed, we found evidence for this when we looked at sub-
jectively perceived social support in a previous single-blind
study from our own group (unpublished results; Schabus
et al., 2014).
The last and most important aim of this study was to
shed light at the mechanisms underlying the efﬁcacy of
NFT by looking at objective measures of the EEG processes
participants were to gain control of. Unfortunately, the
existing NFT literature does not show a particularly
strong tradition in reporting measures of this kind, al-
though without doubt this would greatly beneﬁt the
ﬁeld’s credibility. In the present study we found that despite
NFT and, importantly also PFT, being beneﬁcial on a sub-
jective level, objective measures of EEG activity outside the
training period remain unchanged even when evaluated
only minutes after training (Fig. 3). The latter is also true
for sleep spindles, which are the ﬁrst logical candidates for
parameters which should change as a consequence of SMR-
NFT training (as they lie in the same 12–15Hz frequency
range).
In summary, our results show that patients beneﬁtted
from any treatment on a subjective level. Objectively,
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Figure 3 Short-term effects in the SMR band. A resting EEG (with eyes open) was recorded directly before and after each PFT and NFT
training block. Analyses revealed that even directly following training, patients with insomnia and misperception insomniacs (here pooled) had
SMR amplitude values (on the trained site C3) that did not differ from the values preceding the training blocks. Note that amplitude is normalized
to the individual total-amplitude (1–30 Hz) to account for unspecific differences between participants.
Figure 4 Long-term effects of NFT/PFT training on sleep spindle activity and sleep spindle density. The graphs on the left illustrate
the slow (11–13 Hz) and fast (13–15 Hz) sleep spindle activity (mean spindle amplitude  duration) for the NFT and PFT conditions. The graphs
on the right illustrate sleep spindle density (number of spindles / min). All spindle detections have been performed on (trained) electrode C3 and in
N2 sleep where spindles are most prevalent. Pre and post refer to the mean of two full polysomnography nights before or after 12 sessions of
NFT/PFT. Error bars indicate  1 standard error of the mean (SEM).
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however, this improvement was not reﬂected in EEG-
derived measures. Most importantly, we found that im-
provement of symptoms was not speciﬁc to NFT, but
rather seems to have been brought about by unspeciﬁc fac-
tors such as affection and care. Altogether, it therefore has
to be questioned whether (SMR) neurofeedback can be
promoted as an alternative to established therapeutic
approaches. Our ﬁndings may thereby also stimulate a dis-
cussion regarding the usefulness of neurofeedback on a
more general level. One aspect that may have been
widely neglected until now is the above discussed inﬂuence
of learning abilities that may be compromised in clinical
populations in general.
One may argue that a higher number of training sessions
or individually tailored NFT protocols may be more suc-
cessful in evoking the desired objective changes regarding
brain activity and symptoms and that this may even have
led to a speciﬁc effect for NFT. However, compared to
CBT-I interventions, our protocol was already rather exten-
sive. Moreover, the feedback protocol used here was de-
signed following an extensive review of the literature and in
close coordination with experts in the ﬁeld. We also fol-
lowed up on the idea that our groups may have included
NFT-responders and non-responders. However, approaches
to stratifying our patient group according to various cri-
teria were not successful. This may also be due to there
being no commonly accepted criteria for NFT-(non)-re-
sponders in the literature (Dempster and Vernon, 2009).
Without doubt, there will be patients who are more com-
pliant and possibly more responsive to a modern ‘neu-
rotherapy’ technique like NFT than to CBT-I. Yet, this
justiﬁcation is not enough, especially in times where ﬁnan-
cial resources in the health care systems are limited. We
believe that it is essential that the neurofeedback research
community backs the often far-reaching promises from
little controlled studies by placebo-controlled, double-
blind studies along with adequate sample sizes and
statistical analyses for each of the disorders that efﬁcacy
is claimed for. Similarly, this applies to the ever growing
ﬁeld of EEG-neurofeedback for optimizing performance in
healthy individuals (Gruzelier, 2014).
Based on this comprehensive and well-controlled study, we
conclude that neurofeedback for treating primary insomnia
complaints does not have a speciﬁc efﬁcacy beyond unspe-
ciﬁc factors. Importantly, we do not ﬁnd an advantage for
NFT over PFT and therefore cannot recommend it over the
current non-pharmacological standard-of-care treatment,
that is, CBT-I. Reﬁned study designs and neurofeedback
protocols should be welcomed by the research community,
yet they will have to withstand rigorous testing against real
placebo conditions using double-blind designs.
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Figure 5 Long-term effects of NFT/PFT training on subjective sleep quality (PSQI). The figure depicts the subjective changes in sleep
quality as evaluated with the PSQI. Participants completed the questionnaire before and after the 12 NFT and PFT sessions, as well as 3 months
thereafter (i.e. follow-up). Note a general decrease of sleep complaints from pre- to post-training independent from NFT/PFT and a tendency to
further decrease to the follow-up. A PSQI total score4 5 is indicative of poor sleep (marked with the dashed line). Error bars indicate  1 SEM.
IN = patients with insomnia; MP = misperception insomniacs.
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